Stage III Triple-Negative Breast Cancer: Anne's Survivor Story
This breast cancer diagnosis at a glance
- Stage at diagnosis
- Stage III
- Biomarkers
- ER-negative; PR-negative; HER2-negative (triple-negative)
- Sex
- Female
- Treatment
- chemotherapy, surgery and radiation
- Outcome
- Survivorship / Completed Treatment
Treatment course, step by step
- Eight cycles of chemotherapy during pregnancy; delivery of a healthy baby at 38 weeks; double mastectomy 2 weeks after cesarean delivery; radiotherapy and additional adjuvant chemotherapy.
What happened, in summary
Anne was 11 weeks pregnant with her third child when she was diagnosed on June 11, 2022, with Stage III poorly differentiated metaplastic triple-negative breast cancer. She was building a career in pediatric surgery and expecting a son after two daughters. Her first doctor advised ending the pregnancy to expand treatment options, but Anne sought another opinion and found a team that supported continuing the pregnancy.
She received eight cycles of chemotherapy while pregnant and delivered a healthy 3-kilogram baby boy at 38 weeks. Two weeks after her cesarean delivery, she underwent a double mastectomy, followed by radiotherapy and additional adjuvant chemotherapy. The physical pain after surgery was severe, and treatment unfolded alongside another family crisis: her mother was diagnosed with an aggressive endometrial cancer and later died after recurrence.
Anne remembered the period for loneliness, anger, and pain even when people were around her. She relied on the goal of raising her children and continuing her life rather than allowing the experience to break her. Her message to other patients was to find a reason to smile and a source of meaning while moving through treatment.
Where this story comes from
This is a lay summary of an account first published by breastcancer.org. Read the original in full
How we source and attribute stories Accuracy and limitations
These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer